Safety of Prolonged Intraventricular Administration of Olistin Methanesulphonate

Journal of neuroinfectious diseases Pub Date : 2016-03-18 DOI:10.4172/2314-7326.1000207

Mairi Ziaka, D. Makris, S. Markantonis, E. Zakynthinos

引用次数: 1

Abstract

Mairi Ziaka1, Demosthenes Makris1*, Sophia Markantonis2 and Epaminondas Zakynthinos1 1Critical Care Department, University Hospital of Larissa, Larissa, Greece 2Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Athens, Greece *Corresponding author: Demosthenes Makris, Department of Critical Care Medicine, University Hospital of Larissa,University of Thessaly School of Medicine, Biopolis, Larisa 41000, Greece, Tel: 302413502960; E-mail: dimomakris@med.uth.gr

查看原文本刊更多论文

长时间脑室内给药奥利斯汀的安全性

Mairi Ziaka1, Demosthenes Makris1*， Sophia Markantonis2和Epaminondas Zakynthinos1 1希腊拉里萨大学医院重症监护室2希腊雅典大学药学院生物制药与药代动力学实验室*通讯作者:希腊拉里萨大学医学院拉里萨大学医院重症医学科Demosthenes Makris，希腊拉里萨41000，电话:302413502960;电子邮件:dimomakris@med.uth.gr

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of neuroinfectious diseases

自引率

0.00%

发文量